| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.001 |